Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Clinical trial NCT05946798 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05946798
- Sponsor
- Anna Stanhewicz, PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2026-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.